799 results on '"Fabbri, Chiara"'
Search Results
2. Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder
3. Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis
4. Correction: Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis
5. Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance
6. The clinical perspective on late-onset depression in European real-world treatment settings
7. Polygenic risk scores for mood and related disorders and environmental factors: Interaction effects on wellbeing in the UK biobank
8. Efficacy of the additional use of subgingival air-polishing with erythritol powder in the treatment of periodontitis patients: a randomized controlled clinical trial. Part II: effect on sub-gingival microbiome
9. Biomarkers of treatment-resistant schizophrenia: A systematic review
10. Polygenic scores of subcortical brain volumes as possible modulators of treatment response in depression
11. Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses
12. Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
13. Gambling Disorder in an Italian Population: Risk of Suicide Attempts and Associated Demographic-Clinical Factors using Electronic Health Records
14. Multi-omics data integration methods and their applications in psychiatric disorders
15. Antidepressants: Indications, Contraindications, Interactions, and Side Effects
16. Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns
17. Obsessive-Compulsive, Psychotic, and Autism Dimensions Overlap in Real World: A Case Report
18. Shared genetics linking sociability with the brain's default mode network.
19. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
20. The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review
21. Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation
22. Epigenetics and aetiology of mental illness
23. COVID-19 hospitalization rates in individuals with substance or alcohol use disorders
24. Identifying the Common Genetic Basis of Antidepressant Response
25. The Role of Genetics in Bipolar Disorder
26. Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder
27. Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study
28. A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
29. Genetics of nonpharmacological treatments of depression
30. Local patterns of genetic sharing challenge the boundaries between neuropsychiatric and insulin resistance-related conditions
31. Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis
32. Polygenic scores of subcortical brain volumes as possible modulators of treatment response in depression
33. Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression
34. Melancholic features in major depression – a European multicenter study
35. Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing
36. Genetic underpinnings of sociability in the general population
37. Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts
38. The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?
39. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder
40. The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression
41. Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression
42. Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study
43. Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study
44. Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression
45. Efficacy of the additional use of subgingival air polishing with erythritol powder in the treatment of periodontitis patients: a randomized controlled clinical trial
46. Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder
47. Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts
48. ADVANCING THE GENOMIC PREDICTION OF ANTIDEPRESSANT AND ANTIPSYCHOTIC TREATMENT OUTCOMES
49. F3. METABOLIC EFFECT OF CYP2C19 AND CYP2D6 ON ANTIDEPRESSANT RESPONSE: A META-ANALYSIS OF 13 DEPRESSION PHARMACOGENETIC STUDIES
50. 67. POLYGENIC RISK SCORES FOR MOOD AND RELATED DISORDERS X ENVIRONMENTAL FACTORS: EFFECTS ON WELLBEING IN THE UK BIOBANK
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.